ABSTRACT
Parkinson’s disease (PD) is inversely associated with smoking. Whether this association is due to a causal relationship or to confounding by a covariate of smoking is still debated.
The Institute for Health Metrics and Evaluation (IHME) released refreshed data on October 15, 2020. This study included that recently released data. The study included populations of the United States and ten U.S. states from 2004 to 2018. The ten U.S. states included the five states with the highest PD incidence rates in 2019 (Maine, Vermont, Kansas, Alaska, Missouri) and the five states with the lowest PD incidence rates in 2019 (Arkansas, Mississippi, South Dakota, Nebraska, Delaware). The study used scatter plots to explore the association between PD incidence and smoking and the association between PD incidence and a covariate of smoking, lower endoscopy utilization.
For PD verses smoking, the results indicate that there is an inverse correlation for the United States, but there is no association for the ten states. The coefficient of determination (R2) for the United States was 0.714 and ranged from a low of 0.004 for South Dakota to 0.613 for Mississippi. The average R 2 for the ten states was 0.357.
For PD verses lower endoscopy, the results indicate that the best model fit to the data is a polynomial. When the fitting curve examined in the regression analysis was a 3rd order (cubic) polynomial, there was a positive correlation between PD and lower endoscopy for the United States and for all ten states. The R2 for the US was 0.971 and ranged from a low of 0.709 for Alaska to 0.970 for Kansas. The average R2 for the ten states was 0.878.
The results suggest that the inverse association between PD incidence and smoking is confounded by a positive association between PD and lower endoscopy utilization. Further investigation of a possible relationship between PD incidence and lower endoscopy utilization is warranted and may provide a means for reducing PD incidence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
no approval needed
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
PD incidence rates (age standardized, new cases per 100,000) are available from the Institute for Health Metrics and Evaluation (IHME)'s Global Burden of Diseases, Injuries, and Risk Factors (GBD) Compare visualization system (available at https://vizhub.healthdata.org/gbd-compare). Rates of current smoking (% adults who are current smokers) and rates of lower endoscopy utilization (% who ever had a sigmoidoscopy/colonoscopy) are available from the Centers for Disease Control and Prevention (CDC)'s Behavioral Risk Factor Surveillance System (BRFSS) Web Enabled Analysis Tool (WEAT) (available at https://www.cdc.gov/brfss/data_tools.htm).
